R ARIVANANTHAM
CHENNAI, MAR 9
Strengthening its commitment to advanced cancer diagnosis and treatment, Iswarya Hospital has on Sunday inaugurated the Iswarya Cancer Centre at its OMR–Taramani facility in Chennai, introducing a comprehensive oncology hub equipped with cutting-edge technologies and multidisciplinary cancer care.
- AI-Powered PET-CT, Precision Radiotherapy and Immunotherapy Mark New Era in Cancer Detection
- Actor Sathyaraj inaugurates integrated oncology hub at OMR–Taramani facility
- Multidisciplinary care under one roof including bone marrow transplant, pediatric oncology and theranostics
- Experts highlight alarming rise in cancer cases in India and stress early detection
- Hospital aims to combine advanced technology with compassionate, patient-centred cancer care
The centre was inaugurated by acclaimed actor and public figure Sathyaraj in the presence of CEO S. Rajasundaram, Managing Director Arun Muthuvel and the hospital’s multidisciplinary oncology team.
The newly launched facility brings together a wide spectrum of oncology services under one roof, including surgical oncology, medical oncology, radiation oncology, bone marrow transplant, pediatric oncology, preventive oncology, nuclear medicine and theranostics, onco-pathology and palliative care.
Equipped with advanced operation theatre infrastructure and specialised surgical teams, the centre is designed to perform complex oncological procedures across multiple cancer types while ensuring integrated care for patients at every stage of treatment.
A major highlight of the centre is the deployment of advanced diagnostic and treatment technologies, including AI-powered PET-CT imaging and high-precision radiotherapy systems that significantly enhance the accuracy of cancer detection, staging and treatment delivery.
The centre also offers immunotherapy, an innovative treatment approach that strengthens the body’s immune system to identify and destroy cancer cells more effectively.
Speaking at the launch, S. Rajasundaram said, “Cancer continues to be one of the most significant health challenges in India today. According to the Indian Council of Medical Research and the National Cancer Registry Programme, new cancer cases are projected to rise to around 15.7 lakh cases by 2025, with breast, lung, and oral cancers remaining among the most commonly diagnosed cancers in the country. Breast cancer alone is expected to account for more than two lakh new cases annually, making it the leading cancer among Indian women.”
Highlighting the importance of early diagnosis, Rajasundaram added, “One of the biggest challenges we face is late diagnosis, which significantly reduces survival outcomes. The introduction of AI-powered PET-CT technology and high-precision radiotherapy at the Iswarya Cancer Centre allows us to detect disease earlier, assess its spread more accurately, and guide treatment decisions with greater confidence.”
Arun Muthuvel said, “At Iswarya, our focus has always been on combining advanced technology with compassionate care. The launch of the Iswarya Cancer Centre represents a major milestone in expanding our oncology services. By bringing together expert specialists, complex cancer surgery capabilities, advanced imaging technologies, immunotherapy, and integrated treatment facilities under one roof, we aim to deliver comprehensive cancer care that patients can trust. Early detection and timely treatment are critical to improving outcomes.”
The AI-powered PET-CT scan at the centre integrates advanced imaging with artificial intelligence-driven analysis, enabling clinicians to detect cancer earlier, monitor treatment response more effectively and develop highly personalised treatment strategies for patients.
With the launch of the Iswarya Cancer Centre in OMR–Taramani, the hospital strengthens its mission of providing timely diagnosis, advanced treatment, complex cancer surgeries, high-precision radiotherapy, immunotherapy and multidisciplinary cancer care for patients across Chennai and beyond.
